CI Investments Inc
BBIO icon

CI Investments Inc’s BridgeBio Pharma BBIO Stock Holding History

CI Investments Inc’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-358
Closed -$19K – 708
2025
Q3 		$19K Buy
358
+155
+76% +$7.56K ﹤0.01% 1170
2025
Q2 		$9K Sell
203
-2,962
-94% -$108K ﹤0.01% 1235
2025
Q1 		$109K Sell
3,165
-19
-0.6% -$641 ﹤0.01% 884
2024
Q4 		$87K Buy
3,184
+2,966
+1,361% +$76.7K ﹤0.01% 967
2024
Q3 		$6K Buy
218
+19
+10% +$499 ﹤0.01% 1237
2024
Q2 		$5K Sell
199
-28
-12% -$766 ﹤0.01% 1226
2024
Q1 		$7K Buy
+227
New +$7.72K ﹤0.01% 1235
2022
Q1 		– Sell
-6
Closed – – 1303
2021
Q4 		$0 Hold
6
– – ﹤0.01% 1283
2021
Q3 		$0 Buy
+6
New +$322 ﹤0.01% 1261

Other funds holding BBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CI Investments Inc's BBIO Position: Q4 2025 in Review

CI Investments Inc sold out of BridgeBio Pharma (BBIO) in Q4 2025, closing a stake of 358 shares — an estimated $19K sold.

CI Investments Inc first reported a position in BBIO in Q3 2021 and held it in 9 quarters. The position peaked at $109K in Q1 2025. 433 funds tracked by Wall St. Rank hold BBIO as of Q4 2025.

  • CI Investments Inc reported no remaining BridgeBio Pharma position as of Q4 2025 after selling out during the quarter.
  • CI Investments Inc sold 358 BridgeBio Pharma shares in Q4 2025, an estimated $19K.
  • CI Investments Inc first reported a position in BridgeBio Pharma in Q3 2021 and held it in 9 quarters.
  • CI Investments Inc's BridgeBio Pharma position peaked at $109K in Q1 2025.
  • 433 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q4 2025.

Based on CI Investments Inc's 13F filing for Q4 2025, filed 12 Feb 2026.